GBLX.US GB Sciences Inc

Healthcare Biotechnology USA Stocks
0.0002 USD
Close of Nov 11, 2026
0.0001 0.0020
Market cap
USD 81.4K
P/E
-
P/B
1.08x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Jun 2025.

Is GBLX.US undervalued?

Graham number

The Graham number of GB Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

GB Sciences Inc fundamental analysis

No fundamental analysis for GB Sciences Inc yet.

GB Sciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About GB Sciences Inc

GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, cytokine release syndrome, stress/anxiety/depression, and cardiovascular therapeutic programs. The company was fo…

Full company profile